Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLeMaitre Vascular, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | $0.39 | $0.39 | $0.39 |
| Q2 2024 | 2 | $0.47 | $0.47 | $0.47 |
| Q3 2024 | 2 | $0.43 | $0.44 | $0.44 |
| Q4 2024 | 6 | $0.48 | $0.51 | $0.49 |
| Q1 2025 | 5 | $0.49 | $0.53 | $0.51 |
| Q2 2025 | 4 | $0.55 | $0.58 | $0.57 |
| Q3 2025 | 4 | $0.51 | $0.54 | $0.53 |
| Q4 2025 | 4 | $0.55 | $0.58 | $0.57 |
| Q1 2026 | 3 | $0.54 | $0.57 | $0.56 |
| Q2 2026 | 3 | $0.57 | $0.60 | $0.59 |
| Q3 2026 | 3 | $0.55 | $0.58 | $0.57 |
| Q4 2026 | 3 | $0.59 | $0.62 | $0.61 |
LeMaitre Vascular, Inc. Earnings Date And Information
LeMaitre Vascular, Inc. last posted its earnings results on Thursday, October 31st, 2024. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.44 by $0.05. The company had revenue of 54.82 M for the quarter and had revenue of 193.48 M for the year. LeMaitre Vascular, Inc. has generated $1 earnings per share over the last year ($1.34 diluted earnings per share) and currently has a price-to-earnings ratio of 50.8. LeMaitre Vascular, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
LeMaitre Vascular, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/08/2024 | Q3 2024 | $0.50 | $53.50 M | $54.82 M | ||
| 08/08/2024 | Q2 2024 | $0.53 | $54.98 M | $55.85 M | ||
| 05/10/2024 | Q1 2024 | $0.44 | $53.48 M | |||
| 02/29/2024 | Q4 2023 | $0.38 | $48.88 M | |||
| 11/07/2023 | Q3 2023 | $0.34 | $47.53 M | $47.41 M | ||
| 08/08/2023 | Q2 2023 | $0.36 | $48.08 M | $50.12 M | ||
| 05/09/2023 | Q1 2023 | $0.27 | $47.08 M | |||
| 03/01/2023 | Q4 2022 | $0.26 | $40.95 M | |||
| 11/08/2022 | Q3 2022 | $0.25 | $40.01 M | $39.03 M | ||
| 08/05/2022 | Q2 2022 | $0.16 | $41.39 M | $42.11 M | ||
| 05/10/2022 | Q1 2022 | $0.28 | $39.56 M | |||
| 02/28/2022 | Q4 2021 | $0.28 | $39.50 M | |||
| 11/04/2021 | Q3 2021 | $0.30 | $39.05 M | $38.37 M | ||
| 08/05/2021 | Q2 2021 | $0.40 | $39.57 M | $40.67 M | ||
| 05/10/2021 | Q1 2021 | $0.29 | $35.88 M | |||
| 03/12/2021 | Q4 2020 | $0.35 | $37.55 M | |||
| 11/06/2020 | Q3 2020 | $0.37 | $31.62 M | $36.42 M | ||
| 08/06/2020 | Q2 2020 | $0.17 | $17.12 M | $24.85 M | ||
| 05/08/2020 | Q1 2020 | $0.16 | $30.55 M | |||
| 03/11/2020 | Q4 2019 | $0.23 | $30.17 M |
LeMaitre Vascular, Inc. Earnings: FAQ's
When is LeMaitre Vascular, Inc.'s earnings date?
LeMaitre Vascular, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates.
Did LeMaitre Vascular, Inc. beat their earnings estimates last
quarter?
In the previous quarter, LeMaitre Vascular, Inc. (:LMAT) reported $0.49 earnings per share (EPS) to beat the analysts' consensus estimate of $0.44 by $0.05.
How can I listen to LeMaitre Vascular, Inc.'s earnings conference
call?
The conference call for LeMaitre Vascular, Inc.'s latest earnings report can be listened to online.
How can I read LeMaitre Vascular, Inc.'s conference call transcript?
The conference call transcript for LeMaitre Vascular, Inc.'s latest earnings report can be read online.
How much revenue does LeMaitre Vascular, Inc. generate each year?
LeMaitre Vascular, Inc. (:LMAT) has a recorded annual revenue of $193.48 M.
How much profit does LeMaitre Vascular, Inc. generate each year?
LeMaitre Vascular, Inc. (:LMAT) has a recorded net income of $193.48 M. LeMaitre Vascular, Inc. has generated $1.36 earnings per share over the last four quarters.
What is LeMaitre Vascular, Inc.'s price-to-earnings ratio?
LeMaitre Vascular, Inc. (:LMAT) has a price-to-earnings ratio of 50.8 and price/earnings-to-growth ratio is 5.37.